# High- and Low-dose Radiotherapy Combined With Envafolimab for Metastatic Solid Tumor

> **NCT05755009** · NA · UNKNOWN · sponsor: **Jiangxi Provincial Cancer Hospital** · enrollment: 33 (estimated)

## Conditions studied

- Metastatic Cancer

## Interventions

- **RADIATION:** High- and Low-dose radiotherapy

## Key facts

- **NCT ID:** NCT05755009
- **Lead sponsor:** Jiangxi Provincial Cancer Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-03-01
- **Primary completion:** 2024-02-20
- **Final completion:** 2025-02-20
- **Target enrollment:** 33 (ESTIMATED)
- **Last updated:** 2023-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05755009

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05755009, "High- and Low-dose Radiotherapy Combined With Envafolimab for Metastatic Solid Tumor". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT05755009. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*